Nightingale Informatix Corporation

Nightingale Informatix Corporation develops innovative digital health solutions, including an AI-powered platform that enhances patient engagement and streamlines healthcare data management. Nightingale Informatix Corporation specializes in digital health solutions, primarily through its product Florence, which integrates patient health data to facilitate better care coordination. Founded in Rancho Cordova, US, the company raised USD 3. 5 mn in VENTURE DEBT funding from Beedie Capital in August 2014, bringing its total funding to USD 3.

2 mn. The firm has successfully completed 6 deals since its inception. NightingaleMD offers a comprehensive digital health platform centered around its core product, Florence, an AI-powered health navigator that integrates and simplifies patient health data from various providers. Launched with a focus on enhancing patient engagement and care coordination, Florence unifies lab results, medical notes, and medication records, providing clear, actionable insights in plain language and available in multiple languages.

Targeting patients, healthcare providers, and health plans, Florence serves as a continuous care solution, proactively managing patient health through features such as auto-scheduling of preventive tests, medication tracking, and real-time alerts. The platform is designed to facilitate seamless communication between patients and their healthcare teams, ensuring that critical information is exchanged without the need for traditional paperwork. NightingaleMD's products target markets across the United States, with a commitment to improving healthcare accessibility and efficiency for a diverse population of end-users. NightingaleMD's revenue model is primarily driven by subscription-based partnerships with healthcare providers and health plans.

The firm collaborates with these entities to integrate Florence into their existing systems, enhancing care coordination and patient management. These partnerships enable NightingaleMD to charge for the use of its services, which include healthcare data integration and patient engagement tools. The financial transactions typically occur on a contractual basis, where providers pay for access to the platform and its features, including the flagship Florence product. The company’s revenue structure is supported by the need for healthcare organizations to improve care delivery and patient outcomes, thus driving demand for its innovative solutions.

In August 2014, Nightingale Informatix Corporation raised USD 3. 5 mn in VENTURE DEBT funding from Beedie Capital Partners, which is expected to aid in the expansion of its product offerings and market outreach. The company is actively developing new features for the Florence platform, aiming for a release within the next year to further enhance patient engagement tools. Additionally, NightingaleMD plans to target new geographical markets across North America, with efforts to expand into Canadian provinces by the end of 2025.